Development of α-Tocopherol Acetate Nanoparticles: Influence of Preparative Processes

REFERENCES

• N. Ammoury. (1990). Etude physicochimique et biologique de vecteurs colloidaux vésiculaires d'indométacine––acide polylactique. Ph.D., Thesis, University Paris XI.
   Google Scholar
• N. Ammoury, H. Fessi, J. P. Devissaguet, F. Puisieux, and S. Benita. (1989). Physicochemical characterization of polymeric nanocapsules and in vitro release evaluation of indomethacin as a drug model. STP. Pharma. 5:647–651.
   Google Scholar
• M. Auvillain, G. Cavé, H. Fessi, and J. P. Devissaguet. (1989). Lyophilisation de vecteurs colloidaux submicroniques. STP Pharma. 5:738–744.
   Google Scholar
• C. Bosquillon, P. G. Rouxhet, F. Ahimou, D. Simon, C. Culot, V. Préat, and R. Vanbever. (2004). Aerosolization properties, surface composition and physical state of spray-dried protein powders. J. Control. Release 99:357–367.
   PubMed Web of Science ®Google Scholar
• K. Bouchemal, S. Briançon, E. Perrier, H. Fessi, I. Bonnet, and N. Zydowicz. (2004). Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. Int. J. Pharm. 269:89–100.
   PubMed Web of Science ®Google Scholar
• C. K. Chow, L. H. Chen, R. R. Thacker, and R. B. Griffith. (1984). Dietary vitamin E and pulmonary biochemical responses of rats to cigarette smoking. Environ. Res. 34:8–17.
   PubMed Web of Science ®Google Scholar
• L. A. Dailey, T. Schmehl, T. Gessler, M. Wittmar, F. Grimminger, W. Seeger, and T. Kissel. (2003). Nebulization of biodegradable nanoparticles: Impact of nebulizer technology and nanoparticle characteristics on aerosol features. J. Control. Release 86:131–144.
   PubMed Web of Science ®Google Scholar
• C. Duclairoir, A. M. Orecchioni, P. Depraetere, and E. Nakache. (2002). Alpha-tocopherol encapsulation and in vitro release form wheat gliadin nanoparticles. J. Microencapsul. 19:53–60.
   PubMed Web of Science ®Google Scholar
• H. Fessi, J. P. Devissaguet, and F. Puisieux. (1988). Procédé de préparation de systèmes colloidaux dispersibles d'une substance sous forme de nanoparticules. French Patent. No. 2-608-988.
   Google Scholar
• J. Fiegel, J. Fu, and J. Hanes. (2004). Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. J. Control. Release 96:411–423.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration HHS. (1997). International conference on harmonization: Guidance on impurities: residual solvents. Fed. Regist. 62:67377–67388.
   Google Scholar
• J. Fu, J. Fiegel, E. Krauland, and J. Hanes. (2002). New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 23:4425–4433.
   PubMed Web of Science ®Google Scholar
• K. Fukuzawa, W. Ikebata, and K. Sohmi. (1993). Location, antioxidant and recycling dynamics of (-tocopherol in liposome membranes. J. Nutr. Sci. Vitaminol. 39:S9–S22.
   PubMed Web of Science ®Google Scholar
• R. D. Hautamaki, D. K. Kobayashi, R. M. Senior, and S. D. Shapiro. (1997). Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002–2004.
   PubMed Web of Science ®Google Scholar
• R. Jalil, and J. R. Nixon. (1990). Microencapsulation using poly (l- lactic acid) II: Preparative variables affecting microcapsules properties. J. Microencapsul. 7:25–39.
   PubMed Web of Science ®Google Scholar
• C. E. Johnson. (1989). Principles of nebulizer-delivered drug therapy for asthma. Am. J. Hosp. Pharm. 46:1845–1855.
   PubMedGoogle Scholar
• Y. Kato, K. Watanabe, M. Nakakura, T. Hosokawa, E. Hayakawa, and K. Ito. (1993). Blood clearance and tissue distribution of various formulations of α-tocopherol injection after intravenous administration. Chem. Pharm. Bull. 41:599–604.
   PubMed Web of Science ®Google Scholar
• M. S. Losowsky, J. Kelleher, and B. E. Walker. (1972). Intake and absorption of α-tocopherol. Ann. NY Acad. Sci. 203:212–222.
   PubMed Web of Science ®Google Scholar
• O. N. M. McCallion, K. M. G. Taylor, M. Thomas, and A. J. Taylor. (1996). Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers. Int. J. Pharm. 133:203–214.
   Web of Science ®Google Scholar
• M. C. Newhouse. (1982). Principles of aerosolization therapy. Chest 82S:395–445.
   Google Scholar
• E. R. Pacht, H. Kaseki, J. R. Mohammed, D. G. Cornwell, and W. B. Davis. (1986). Deficiency of vitamin E in the alveolar fluid of cigarette smokers. J. Clin. Invest. 77:789–796.
   PubMed Web of Science ®Google Scholar
• K. Panda, R. Chattopadhyay, M. K. Ghosh, D. J. Chattopadhyay, and I. B. Chatterjee. (1999). Vitamin C prevents cigarette smoke induced oxidative damage of proteins and increased proteolysis. Free. Radic. Biol. Med. 27:1064–1079.
   PubMed Web of Science ®Google Scholar
• D. Quintanar-Guerrero, H. Fessi, E. Alléman, and E. Doelker. (1996). Influence of stabilizing agents and preparative variables on the formation of poly (D, L-lactic acid) nanoparticles by an emulsification-diffusion technique. Int. J. Pharm. 143:133–141.
   Web of Science ®Google Scholar
• D. Roy, X. Guillon, F. Lescure, P. Couvreur, N. Bru, and P. Breton. (1997). On shelf stability of freeze-dried poly (methylidene malonate 2.1.2) nanoparticles. Int. J. Pharm. 148:165–175.
   Web of Science ®Google Scholar
• M. Scherrer-Crosbie, M. Paul, M. Meignan, E. Dahan, G. Lagrue, G. Atlan, and A. M. Lorino. (1996). Pulmonary clearance and lung function: Influence of acute tobacco intoxication and of vitamin E.. J. Appl. Physiol. 81:1071–1077.
   PubMed Web of Science ®Google Scholar
• B. Schmekel, J. A. H. Bos, A. R. Khan, B. Wohlfart, B. Lachmann, and P. Wollmer. (1992). Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. Thorax 47:603–608.
   PubMed Web of Science ®Google Scholar
• H. Schreier, R. J. Gonzalez-Rothi, and A. A. Stecenko. (1993). Pulmonary delivery of liposome. J. Control. Release 24:209–223.
   Web of Science ®Google Scholar
• P. N. Shek, Z. E. Suntres, and J. I. Brooks. (1994). Liposomes in pulmonary applications: Physicochemical considerations, pulmonary distribution and antioxidant delivery. J. Drug. Target. 2:431–442.
   PubMed Web of Science ®Google Scholar
• A. A. Shvedova, E. R. Kisin, A. R. Murray, O. Gorelik, S. Arepalli, V. Castranova, S. H. Young, F. Gao, Y. Y. Tyurina, T. D. Oury, and V. E. Kagan. (2007). Vitamin e deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. Toxicol. Appl. Pharmacol. 221:339–348.
   PubMed Web of Science ®Google Scholar
• S. Stolnik, M. C. Davies, L. Illum, S. S. Davis, M. Boustta, and M. Vert. (1994). The preparation of sub -200 nm biodegradable colloidal particles from poly (malic acid-co-benzyl-malate) copolymers and their surface modification with poloxamer and poloxamine surfactants. J. Control. Release 30:57–67.
   Web of Science ®Google Scholar
• Z. E. Suntres, S. R. Hepworth, and P. N. Shek. (1992). Protective effect of liposome associated α-tocopherol against paraquat- induced acute lung toxicity. Biochem. Pharmacol. 44:1811–1818.
   PubMed Web of Science ®Google Scholar
• Z. E. Suntres, and P. N. Shek. (1995a). Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat. Biomed. Environ. Sci. 8:289–300.
   PubMedGoogle Scholar
• Z. E. Suntres, and P. N. Shek. (1995b). Prevention of phorbol-myristate acetate-induced acute lung injury by α-tocopherol liposomes. J. Drug. Target. 3:201–208.
   PubMed Web of Science ®Google Scholar
• A. M. Taburet, and B. Schmit. (1994). Pharmacokinetic optimization of asthma treatment. Clin. Pharmacokinet. 26:396–418.
   PubMed Web of Science ®Google Scholar
• M. C. Venier-Julienne, I. Vouldoukis, L. Monjour, and J. P. Benoit. (1995). In vitro study of the antileishmanial activity of biodegradable nanoparticles. J. Drug. Target. 3:23–29.
   PubMed Web of Science ®Google Scholar
• M. Zaru, S. Mourtas, P. Klepetsanis, A. M. Fadda, and S. G. Antimisiaris. (2007). Liposomes for drug delivery to the lungs by nebulization. Eur. J. Pharm. Biopharm. 67:655–66.
   PubMed Web of Science ®Google Scholar